Bausch & Lomb (BLCO) Amortization of Deferred Charges (2022 - 2026)
Bausch & Lomb's (BLCO) quarterly Amortization of Deferred Charges came in at $4.0 million in Q2 2026, down 20.0% YoY from $5.0 million in Q2 2025, and up 33.33% on a QoQ basis from $3.0 million in Q1 2026.
Bausch & Lomb (BLCO) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 5 years of Amortization of Deferred Charges data on file, last reported at $4.0 million in Q2 2026.
- Quarterly Amortization of Deferred Charges fell 20.0% year-over-year to $4.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $15.0 million (down 25.0% YoY) and the FY2025 annual result came in at $18.0 million, down 10.0% from the prior year.
- Amortization of Deferred Charges improved to $4.0 million in Q2 2026, from $3.0 million in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $19.0 million in Q3 2023 to a low of $2.0 million in Q2 2022.
- A 5-year average of $4.9 million and a median of $4.0 million in 2025 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2023 — Amortization of Deferred Charges jumped 533.33% — and 2024, when it tumbled 73.68%.
- Tracing BLCO's Amortization of Deferred Charges over 5 years: stood at $3.0 million in 2022, then soared by 66.67% to $5.0 million in 2023, then changed by 0.0% to $5.0 million in 2024, then slipped by 20.0% to $4.0 million in 2025, then changed by 0.0% to $4.0 million in 2026.
- The last three Amortization of Deferred Charges figures came in at $4.0 million (Q2 2026), $3.0 million (Q1 2026), and $4.0 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.00 Mn |
| Jun 30, 2026 | 4.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 5.00 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Mar 31, 2024 | 5.00 Mn |